ImageneBio, Inc. Reports Q2 2026 Financial Results

What Happened
ImageneBio, Inc. (IMA) filed a Form 8-K on August 5, 2026 (Item 2.02) announcing its financial results for the quarter ended June 30, 2026. The company attached a press release with the results as Exhibit 99.1 to the filing and included its Cover Page Interactive Data File (Inline XBRL) as Exhibit 104 (Item 9.01).

Key Details

• Form 8-K filed on August 5, 2026 reporting quarterly results for the period ended June 30, 2026.
• Press release with the financial results is attached as Exhibit 99.1.
• Inline XBRL cover page (machine-readable financial data) is included as Exhibit 104.

Why It Matters
Quarterly financial results provide updated information on earnings, revenue, cash position and operational trends that investors use to evaluate the company’s performance and outlook. This 8-K signals that detailed figures and commentary are available in the attached press release (Exhibit 99.1); investors should review that release and the Inline XBRL data for the specific revenue, expense, and cash metrics before making investment decisions.